Mesotherapy: myth and reality
April 2011
in “Expert Review of Dermatology”
TLDR Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.
The document from 2011 critically reviews mesotherapy, a procedure involving injections of substance mixtures for fat dissolution, skin rejuvenation, and alopecia treatment. It points out the absence of large, randomized controlled trials to validate the efficacy and safety of mesotherapy, with most data coming from single case reports and small series. The ingredients in mesotherapy, which are not FDA-approved for subcutaneous use, vary and lack transparency in concentration disclosure. Specifically, phosphatidylcholine, the main ingredient purported to dissolve fat, has not been proven effective in trials. The document also mentions that while some studies suggest mesotherapy may improve skin texture, they lack long-term follow-up, and there are no controlled studies confirming its effectiveness for alopecia, with some reports of treatment-induced alopecia. The authors highlight the occurrence of side effects such as infections, allergic reactions, and granulomatous inflammation, and advise extreme caution in the practice of mesotherapy due to these risks and the lack of supporting evidence. They call for controlled trials to establish the safety and benefits of mesotherapy and suggest that future regulations should be based on scientific evidence.
View this study on tandfonline.com →
Cited in this study
research Alopecia secondary to mesotherapy
Some people experienced hair loss after mesotherapy treatments for hair loss.
research Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study
Both mesotherapy treatments reduced under-chin fat equally and were safe with mild side effects.
Related
research Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia
Some plants like spinach, broccoli, and matcha may boost the effectiveness of the hair growth drug minoxidil.
research Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.
research The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years
research Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment
Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.
research Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial
Mesotherapy is more effective than topical spray for female hair loss treatment.
research A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
5% minoxidil works better for hair growth and density, with minor irritation.
research Androgenetic alopecia: Treatment results with topical minoxidil
Topical minoxidil is a safe and effective treatment for hair loss caused by androgenetic alopecia.
research Topical Minoxidil Therapy and Hair Regrowth
Minoxidil helps hair regrowth, especially with more indeterminate hairs.